Azithromycin noninferior to doxycycline for chlamydia
BRISBANE, AUSTRALIA – Azithromycin has been shown to be noninferior to doxycycline in the treatment of chlamydia, in a randomized clinical trial conducted in a youth correctional facility.
The study, presented at the World STI & HIV Congress 2015, found a 7-day, twice-daily regimen of 100 mg...
Source: Skin and Allergy News - Category: Dermatology Source Type: news
More News: Allergy | Allergy & Immunology | Azithromycin | Chlamydia | Clinical Trials | Dermatology | Doxycycline | Politics | Skin | Study | Zithromax